Mario Brkulj
👨🏻🦳 20+ years in #biopharma #investorrelations & #communications
👱🏼♂️Former journalist, MorphoSys spokesperson, and MacDougall EU practice lead
👉🏻Today: Valency Communications owner
@fgbonadonna.bsky.social
FGB promotes therapeutic innovation from the earliest phases of research and the education of new generations of physician-scientists in Oncology
@cafepharma.bsky.social
The original site for employees in pharma, medical, and diagnostic sales and related industries. Join us and stay informed.
@amgen.bsky.social
Our mission is to serve patients with a cutting-edge, science-based approach. 🔗 https://wwwext.amgen.com/
@drniksharma.bsky.social
CEO and co-founder at BioCorteX, bacteria, data, ML, scientist, clinician (neurologist)
@mattokrebs.bsky.social
BioCentury Inc. ( www.biocentury.com ) * Strategic Sales Leader | Empowering Biopharma & Finance Execs | Travel Junkie * Global Strategic Account Manager & Growth Team Sales Manager
@marisakurz.bsky.social
Ärztin, Biochemikerin, Kolumnistin, Hundemama https://www.spektrum.de/profil/kurz/marisa/2042338
@thommyjb.bsky.social
💚🇩🇪 🇪🇺 - Erneuerbare Energie - Nachhaltigkeit - Wasserstoff/Hydrogen und Batterie - Wärmepumpe - Demokratie
@spicebirdvogelmann.bsky.social
Europäer🇪🇺 parteiloser Demokrat💚 fckputin🇺🇦 fckafd🚮 fckhamas🇮🇱 Ehemann.Vater von 2 Studierenden. Ing.Food.Pharma.Biotech🫚💊💉🧫 Protestant🙏Württemberger🍷S04⚽ Klima.Biodiversität.Menschenwürde.
@jdpluess.bsky.social
Pharma and healthcare reporter at SWI swissinfo.ch (Swiss Broadcasting Corp)
@firstwordgroup.com
FirstWord is a global leader in news and intelligence for the Pharma and MedTech industries. Find our services here www.firstwordpharma.com, www.firstwordhealthtech.com, and www.firstwordreports.com
@sauer-lab.bsky.social
@uni-wuerzburg.de
Science for Society. Since 1402. Impressum: http://go.uniwue.de/impressum
@abaerbock.diplo.de
Offizieller Bluesky Account von Außenministerin Annalena Baerbock | Official Bluesky Account of Foreign Minister Annalena Baerbock
@habeck4kanzler.bsky.social
Wenn du Robert Habeck 2025 im Kanzleramt sehen willst, kannst du diesem Account bedenkenlos folgen. #Habeck4Kanzler #Habeck #TeamRobert #TeamHabeck Feed: https://bsky.app/profile/habeck4kanzler.bsky.social/feed/aaagdkegeov24
@bolekz.bsky.social
Director of Digital & Data Science, discovery pharmacology, transforming drug discovery with AI & digitalization. Bioimaging/data scientist. Marine Bio enthusiast. Globetrotter wannabe.
@nicoledefeudis.bsky.social
Biopharma reporter at Endpoints News | nicole@endpointsnews.com
@jaredwhitlock.bsky.social
features editor @endpts.com / fall 2021 fellow @ksjatmit.bsky.social Writing (and editing) stories on rare disease medicine, diagnostics and China Reach out privately on Signal: jaredwhitlock.73
@shelbylivingston.bsky.social
Reporter covering health tech for Endpoints News. Formerly Business Insider and Modern Healthcare. Charleston native, Clemson alum. Go Tigers!
@nicolewetsman.bsky.social
deputy editor @endpts.com // formerly the verge & abc news // soccer posts
@maxgelman.bsky.social
Reporting on pharma and biotech for Endpoints News. Baseball fan, Northwestern alum.
@maxbayer.bsky.social
Pharma reporter at Endpoints News | Past: Fierce Biotech and CBS News | mbayer@endpointsnews.com or chat me for Signal. he/him
@leileiwu.bsky.social
reporting on drugs and biotechs @endpoints • email me: lwu@endpointsnews.com • Signal: leileiwu.24 • ✌️
@kylelahucik.bsky.social
reporting on the $, people & startups in the biotech world for Endpoints News | klahucik@endpointsnews.com | also coach high school XC + Track & Field team | askin Qs, joggin 26.2 | 🌎🏳️🌈🏃🏻♂️🗞️💨
@drewsnews.bsky.social
Endpoints News executive editor -- where the business of medicine gets answers. Posts on biotech, pharma, drugs, financial markets science and business (and how they all intersect). #biosky Priors: Bloomberg News + the Covid vaccine tracker. CQ.
@andrewedunn.bsky.social
Reporter @ Endpoints News Covering biotech, pharma, AI, and more — the future of medicine adunn@endpointsnews.com
@endpts.com
We're where the business of medicine gets answers. An independent news media organization covering biotech, pharma, science, policy, finance, venture capital and markets, and how they drive the life sciences industry. Read us at www.endpts.com.
@grunewald.bsky.social
Assistant Professor at TUM. CRISPR tech dev, cardiovascular gene & cell therapies. https://www.cos.tum.de/en/cos/research/gruenewald-lab/
@schmidts.bsky.social
Emmy Noether group leader & MD. CAR-T cells, cell therapy, immunotherapy, cancer research.
@ccortimd.bsky.social
MD, Research Fellow, Dana-Farber #Breast Onc • Medical Oncologist from IEO/UniMi 🇮🇹• Editor @PLOSDigiHealth • Epistemic diversity enthusiast. • #FirstGen • Rock lover 🎸
@daphnezohar.bsky.social
Founder & CEO of www.SeaportTx.com developing new medicines for neuropsychiatric disorders. Co-founder Karuna Tx (KarXt/Cobenfy now at BMS). Founding CEO & Senior Advisor www.puretechhealth.com. Co founder/host @BiotechCH. Board of BIO #Biotech #BioSky
@ptarantinomd.bsky.social
Breast Medical Oncologist, Advanced Fellow Dana-Farber | Harvard | PhD Unimi. SoMe Editor ESMO Open. Interested in breast oncology, HER2, ADCs and good music.
@cancerassassin1.bsky.social
Physician-Scientist/Clinical Cancer Biologist/GI Medical Oncologist. In lab: Cancer Cell Biology, uncovering how #TunnelingNanotubes drive ChemoResistance. https://med.umn.edu/dom/divisions/hematology-oncology-and-transplantation/research/emil-lou-lab
@sdanson1.bsky.social
Professor of Medical Oncology (melanoma and early phase), Ex vivo Clinical Lead & School Director of Research, Sheffield, UK
@pateloncology.bsky.social
Professor, Medical Oncology @UCSD; Phase 1 & thoracic/NSCLC immunotherapy, solid tumor cell therapy, spatial biology, irAEs, wearables, cancer informatics & AI
@andreigoga.bsky.social
Professor, UCSF Dept Cell & Tissue Biology and Medicine / Oncology Breast Medical Oncologist and Cell Biology. Exploring new mechanisms of cancer biology & therapeutics. Views my own. 🧪 #medsky Oncogenes.net
@thewonkologist.bsky.social
Medical oncologist and health services researcher. Focusing on health care costs, physician-industry COI, and oncology reimbursement reform. Opinions mine.
@dan5tanton.bsky.social
B2B life sciences journalist specialising in biomanufacturing. CDMOs, supply chain, etc but with a love for the Beatles, politics, art and culture (when most pretentious), and life! London born but in Montpelllier, France for the cheap wine and easy life
@scicommstudios.bsky.social
#scicomm #sciart. I work in Cinema4D to bring you images and videos of science. (Journal covers, book covers, web content...etc. drop me a message if you need visuals to promote your work)💊🐡🧫🧪⚗️🧶🧬 www.scicommstudios.co.uk
@codyshirriff.bsky.social
A biotech aficionado living in Vancouver. Made shredy.ca after years of working with technical consultants for SR&ED.
@biorxivpreprint.bsky.social
@gilman.bsky.social
Scientist, entrepreneur, ex-biopharm exec, former FM radio jock, lifelong hockey fan, aspiring guitar player and mixologist, #immigrant, #BioSky. CEO, Arrakis Therapeutics and a variety of other things. https://www.michaelgilman.net/disclosures/
@jeffbarrett.eu
USA->UK->Finland. Posting about 'omics technologies and the great outdoors (among other things).